Guyasuta Investment Advisors Inc. reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 1.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,075 shares of the company’s stock after selling 1,105 shares during the […]
Intrust Bank NA cut its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 8.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 31,947 shares of the company’s stock after selling 2,975 shares during the quarter. Intrust Bank NA’s holdings […]
Kestra Private Wealth Services LLC raised its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 6.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 215,521 shares of the company’s stock after acquiring an additional 12,477 shares during the […]
Investment House LLC grew its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 122,379 shares of the company’s stock after buying an additional 743 shares during […]
Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for shares of Merck & Co., Inc. in a research report issued on Friday, April 26th. Cantor Fitzgerald analyst L. Chen now forecasts that the company will post earnings of $8.53 per […]